(Q39665986)

13 September 2017

1 reference

title

Perspectives on the potential for successful development of outer membrane protein vaccines (English)

1 reference

13 September 2017

1 reference

H E Gilleland

1

1 reference

PubMed ID

3305003

13 September 2017

J M Matthews-Greer

series ordinal

2

1 reference

PubMed ID

3305003

13 September 2017

language of work or name

1 reference

1 June 1987

1 reference

European journal of clinical microbiology

13 September 2017

1 reference

13 September 2017

6

1 reference

13 September 2017

231-233

1 reference

13 September 2017

3

1 reference

Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.

13 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02017606

Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02017606

Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody.

21 January 2018

1 reference

12 December 2020

Architecture of the Outer Membrane of Escherichia coli III. Protein-Lipopolysaccharide Complexes in Intramembraneous Particles

1 reference

12 December 2020

Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F

1 reference

12 December 2020

Intrinsic antibiotic resistance of Pseudomonas aeruginosa.

1 reference

12 December 2020

Permeability of the Outer Membrane of Bacteria

1 reference

12 December 2020

Evidence for the importance of O antigen specific antibodies in mouse-protective Salmonella outer membrane protein (porin) antisera.

1 reference

12 December 2020

O-antigenic chains of lipopolysaccharide prevent binding of antibody molecules to an outer membrane pore protein in Enterobacteriaceae

1 reference

12 December 2020

Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies

1 reference

12 December 2020

Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein

1 reference

12 December 2020

Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants

1 reference

12 December 2020

Freeze-etch study of Pseudomonas aeruginosa: localization within the cell wall of an ethylenediaminetetraacetate-extractable

1 reference

12 December 2020

Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.

1 reference

12 December 2020

Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins

1 reference

12 December 2020

Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide

1 reference

12 December 2020

Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b.

1 reference

12 December 2020

Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Status of a group B Neisseria meningitidis vaccine

1 reference

12 December 2020

Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02017606

1 reference

13 September 2017

1 reference

PubMed ID

3305003